Chimera Bioengineering Company

Chimera solves the challenges of CARs with drug-responsive gene regulators, which allow us to re-program of the immune system.
Technology: Cell therapy, Neurological Disorders
Industry: PharmTech, Private
Headquarters: South San Francisco, California, United States
Founded Date: 2015-01-01
Employees Number: 11-50
Investors Number: 5
Total Funding: 30700284
Estimated Revenue: $1M to $10M
Last Funding Date: 2022-04-28
Last Funding Type: Grant

Visit Website
Register and Claim Ownership